News

Bain Capital-backed Heartflow eyes $1.32 billion valuation as medtech IPOs rebound

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO

(Reuters) -Healthcare firm Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its initial public offering in the United States. The Mountain View, California-based company ...
Contract Pharma3d

BMS, Bain Capital Form New Independent Biopharma Company

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...